CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioPharma Dive
Original article

Sarepta, in search of a turnaround, taps ex-AbbVie exec Severino as CEO

ElevidysNegative
AI Analysis

Summary

Sarepta Therapeutics appoints Severino, former AbbVie executive and most recently CEO of Tessera Therapeutics, as new CEO to lead company turnaround amid emerging competition and declining sales for its gene therapy Elevidys.

Importance:5/10
Sentiment:
-0.30
management changeCEO appointmentcompetitiondeclining salesturnaround
Related Companies

Read the original article

Published by BioPharma Dive on July 27, 2026 2:16 PM

Read Original